BioWorld MedTech

June 3, 2016

View Archived Issues

China Resources exits med-tech space to focus on other health care areas

Read More

FDA clarifies how IDE categories work as they relate to Medicare coverage

Read More

Financings

Read More

Appointments & Advancements

Read More

Other news to note

Read More

Product briefs

Read More

Keeping you up to date on recent developments with diagnostics

Read More

FDA approves first liquid biopsy test to aid clinical decisions based on EGFR mutation

Roche Holding AG, of Basel, Switzerland, is the first company with an FDA-approved, blood-based genetic test to detect a gene mutation associated with the most common type of lung cancer. Read More

France's AAA gets FDA win for Netspot to locate rare tumors

Read More